Skip to main content

Table 3 Univariate and multivariate Cox regression analysis for OMG conversion and CSR

From: Thymectomy in ocular myasthenia gravis—prognosis and risk factors analysis

 

Univariate

Multivariate

HR (95% CI)

p value

HR (95% CI)

p value

Conversion

 RNS (+)

7.462 (1.651–33.718)

0.009*

6.007 (1.316–27.412)

0.021*

 Anti-AchR Ab (+)

6.428 (0.832–49.681)

0.075

  

 B2/B3 thymoma versus Hyperplasia + AB/B1 thymoma

5.987 (1.325–27.044)

0.020*

4.611 (1.010–21.043)

0.048*

CSR

 Onset age > 60 versus ≤ 60

0.230 (0.052–1.011)

0.052

  

 RNS (+)

0.378 (0.122–1.175)

0.093

  

 Anti-AchR Ab (+)

0.396 (0.147–1.068)

0.067

  

 Stage II/III thymoma versus Hyperplasia + stage I thymoma

0.300 (0.104–0.864)

0.026*

0.300 (0.104–0.864)

0.026*

  1. Values in boldface as well as * indicate statistically significant
  2. CSR complete stable remission, OMG ocular myasthenia gravis, AChR-ab anti-acetylcholine receptor antibody, RNS repetitive nerve stimulation, HR hazard ratio
  3. *Statistically significant